Bernstein Initiates Regeneron Pharmaceuticals At Outperform By: Benzinga via Benzinga February 17, 2015 at 08:04 AM EST Analysts at Bernstein initiated coverage on Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) with a Outperform rating. The target price ... Read More >> Related Stocks: Regeneron Pharmaceuticals